Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BIVI
BIOVIE INC.
NASDAQ
$2.16
▼ DOWN 1.37% (-0.03)

KEY STATISTICS

Market Cap$16.29 M
52w High$3.79
52w Low$0.82
Dividend Yield—
Frequency—
P/E-0.69
Volume482.38K
Shares Out.7.54M

COMPANY

LEADERSHIP

Cuong Viet Do
CHIEF EXECUTIVE
Cuong Viet Do

COMPENSATION 2026

Salary$618,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$860,149

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 18, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
13

UPCOMING EARNINGS

DateNov 9, 2026
DayMonday
Rev. Est.—
NOV
9
MON

SPLIT RECORD

DATETYPERATIO
2025-07-07Reverse1:10
2024-08-06Reverse1:10
2019-11-25Reverse1:125
2019-11-22Reverse1:125

PRICE

$2.16 ▼ DOWN 1.37% (−$0.03)
OVERLAYS
$2.12$2.16$2.20$2.249:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.16

About BioVie Inc.

https://bioviepharma.com ↗

BioVie Inc. is a clinical-stage biotech company developing drugs like BIV201 and NE3107 for liver cirrhosis, Alzheimer's, Parkinson's, multiple myeloma, and prostate cancer.

INDUSTRY

Biotechnology

A PRODUCT BIOVIE INC. IS KNOWN FOR

Bezisterim (NE3107)
Bezisterim (NE3107)

Bezisterim, BioVie's flagship oral small molecule drug, crosses the blood-brain barrier to target inflammation and insulin resistance, aiming to treat neurodegenerative diseases like Parkinson's, Alzheimer's, and Long COVID.

COMPETITORS

COMPETITOR
ANVS COMPARE
AVXL COMPARE
BIIB COMPARE
LLY COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 70.9K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
19.79%
HOLDERS
48
TOP 12 OF 48 · RANKED BY POSITION SIZE
Diametric Capital, LP
370.0K sh · $518K
Swisspartners Ltd.
294.3K sh · $2.29M
Vanguard Group Inc
213.5K sh · $247.7K
Drw Securities, LLC
128.4K sh · $148.89K
Prelude Capital Management, LLC
92.1K sh · $128.89K
Geode Capital Management, LLC
84.2K sh · $117.88K
Morgan Stanley
75.2K sh · $105.31K
Philadelphia Trust Co
75.0K sh · $105K
Renaissance Technologies LLC
67.9K sh · $95.08K
Citadel Advisors LLC
45.3K sh · $63.41K
Hrt Financial LP
23.5K sh · $32K
Aj Wealth Strategies, LLC
23.5K sh · $101.17K

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book4
Overall Score3

INSIDER TRADES

★
OFFICER: CHIEF MEDICAL OFFICER
Palumbo Joseph M
Purchase · 4.8K shares
2026-08-28
★
DIRECTOR
Chappell Amy Suzon
Purchase · 727 shares
2026-08-28
★
OFFICER: CHIEF FINANCIAL OFFICER
KIM JOANNE WENDY
Purchase · 2.5K shares
2026-08-28
★
DIRECTOR, OFFICER: PRESIDENT & CEO
DO CUONG V
Purchase · 15.2K shares
2026-08-27

SECTORS PEERS

PEERPRICE
KZIA$13.58COMPARE
GLMD$4.17COMPARE
INM$1.38COMPARE
ELAB$5.31COMPARE
ARTL$0.66COMPARE
CERO$0.01COMPARE
OCEA$0.00COMPARE
LIPO$0.00COMPARE